ALCRESTA
Alcresta is developing and commercializing innovative, point-of-care, enzyme-based nutritional products that support improved nutrition and manage disease for infants, aging adults and people battling acute conditions or chronic diseases. Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development and commercialization of its programs. The company’s platform is supported by the Alcresta team’s proven success in developing protein therapeutics.
ALCRESTA
Industry:
Biotechnology Health Care Medical Device
Founded:
2011-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.alcresta.com
Total Employee:
11+
Status:
Active
Contact:
617-916-1207
Total Funding:
139.39 M USD
Technology used in webpage:
ReCAPTCHA CrUX Dataset CrUX Top 50m ReCAPTCHA V3 Verizon Verizon FIOS
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Daniel Orlando CEO @ Alcresta
CEO
2019-06-01
Shaheda Ahmed Senior Scientific Officer @ Alcresta
Senior Scientific Officer
2010-09-01
William Scheinler Chief Legal Officer @ Alcresta
Chief Legal Officer
2016-04-01
Chris Parrish Chief Operations Officer @ Alcresta
Chief Operations Officer
Anastasios Konidaris Chief Financial Officer @ Alcresta
Chief Financial Officer
Jason Weiner Chief Commercial Officer @ Alcresta
Chief Commercial Officer
2020-07-27
Alexey Margolin Director @ Alcresta
Director
2011-09-01
Founder
Investors List
HealthQuest Capital
HealthQuest Capital investment in Series C - Alcresta
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Alcresta
Bessemer Venture Partners
Bessemer Venture Partners investment in Series B - Alcresta
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Alcresta
Third Rock Ventures
Third Rock Ventures investment in Series B - Alcresta
Third Rock Ventures
Third Rock Ventures investment in Series A - Alcresta
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Alcresta
Bessemer Venture Partners
Bessemer Venture Partners investment in Series A - Alcresta
Key Employee Changes
Official Site Inspections
http://www.alcresta.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.23 K
- Host name: 104.21.84.112
- IP address: 104.21.84.112
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alcresta"
About Us | Alcresta Therapeutics
About Alcresta Therapeutics. Alcresta develops novel products that deliver enzymatic solutions to those living with rare diseases. Based in Massachusetts, Alcresta Therapeutics has achieved …See details»
Alcresta - Crunchbase Company Profile & Funding
Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s …See details»
Alcresta Therapeutics - LinkedIn
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare ...See details»
Alcresta Therapeutics
Alcresta develops rare disease, enzyme-based products helping to address fat malabsorption (often due to exocrine pancreatic insufficiency) in patients who are enterally fed at home or in …See details»
Alcresta Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alcresta Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Alcresta: Revenue, Worth, Valuation & Competitors 2025
About Alcresta. Alcresta is a Medical Equip related company founded in 2011 and based in Newton with 68 employees an estimated revenue of $17.1M, and. It has 10 competitors …See details»
Alcresta Therapeutics Announces Expansion of Leadership Team …
WALTHAM, MA, March 3, 2025—Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today …See details»
Alcresta Therapeutics 2025 Company Profile: Valuation, …
Alcresta Therapeutics General Information Description. Developer of enzyme-based products designed to combat gastrointestinal disorders. The company's digestive enzyme cartridge has been designed to mimic the function of …See details»
Alcresta Therapeutics Company Profile | Management and
Alcresta Therapeutics Profile and History Alcresta Therapeutics develops enzyme-based products to address fat malabsorption in patients with rare diseases who require enteral feeding. Their …See details»
Alcresta - VentureRadar
Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with gastrointestinal …See details»
Alcresta Company Profile - Office Locations, Competitors ... - Craft
Alcresta is a company developing and commercializing innovative enzyme-based nutritional products that support improved nutrition and manage the disease for infants, aging adults and …See details»
Alcresta - Funding, Financials, Valuation & Investors - Crunchbase
Alcresta is funded by 4 investors. HealthQuest Capital and Bessemer Venture Partners are the most recent investors. Alcresta has a post-money valuation in the range of $100M to $500M …See details»
Alcresta Therapeutics, Inc. - MassBio
Alcresta Therapeutics is a company dedicated to developing and commercializing novel enzyme-based products designed to address challenges faced by people living with gastrointestinal …See details»
Alcresta Therapeutics Expands Leadership Team | citybiz
Mar 3, 2025 Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced several …See details»
Linden Capital Partners acquires Alcresta Therapeutics inc.
Chicago, IL and Waltham, MA (March 12, 2024) – Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the …See details»
ALCRESTA THERAPEUTICS ANNOUNCES EXPANSION OF …
Mar 3, 2025 Alcresta Therapeutics, Inc. is backed by Linden Capital Partners and HealthQuest Capital. More information can be found at www.alcresta.com . Internal Media Contact: Natalie …See details»
Alcresta Therapeutics - Products, Competitors, Financials, …
Jason Weiner, formerly Chief Commercial Officer at Alcresta, has taken on the new role of Chief Strategy and Business Development Officer. Since 2020, Mr. Weiner has led the Alcresta …See details»
Alcresta - Contacts, Employees, Board Members, Advisors & Alumni
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Linden Invests in Alcresta Therapeutics
Mar 12, 2024 We have been impressed with the organization and team that Daniel has built and are excited to partner with Alcresta on this next phase of growth.” Linden’s Ernest Waaser and …See details»
Working at Alcresta Therapeutics - Zippia
Mar 14, 2024 Alcresta's core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development …See details»